Log in to save to my catalogue

Exploring nordihydroguaretic acid (NDGA) as a plausible neurotherapeutic in the experimental paradig...

Exploring nordihydroguaretic acid (NDGA) as a plausible neurotherapeutic in the experimental paradig...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2559428021

Exploring nordihydroguaretic acid (NDGA) as a plausible neurotherapeutic in the experimental paradigm of autism spectrum disorders targeting nitric oxide pathway

About this item

Full title

Exploring nordihydroguaretic acid (NDGA) as a plausible neurotherapeutic in the experimental paradigm of autism spectrum disorders targeting nitric oxide pathway

Publisher

New York: Springer US

Journal title

Metabolic brain disease, 2021-10, Vol.36 (7), p.1833-1857

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

The present study investigates the neuro-protective ability of nordihydroguaretic acid (NDGA) in the experimental paradigm of autism spectrum disorders (ASD) and further decipher the nitric oxide pathway’s role in its proposed action. An intracerebroventricular infusion of 4 μl of 1 M PPA was given in the lateral ventricle’s anterior region to indu...

Alternative Titles

Full title

Exploring nordihydroguaretic acid (NDGA) as a plausible neurotherapeutic in the experimental paradigm of autism spectrum disorders targeting nitric oxide pathway

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2559428021

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2559428021

Other Identifiers

ISSN

0885-7490

E-ISSN

1573-7365

DOI

10.1007/s11011-021-00811-7

How to access this item